ARTICLE | Distillery Therapeutics
Cancer
July 31, 2017 7:19 PM UTC
In vitro and cell culture studies identified a hydrazone-based inhibitor of RRM1 that could help treat breast, colorectal and pancreatic cancers. In silico screening of a small molecule library and te...
BCIQ Company Profiles